Coupled with its role in inhibiting the protein synthesis in cancer cells [33, 34], controlling gluconeogenesis and glucose uptake and influencing insulin/ IGF-1 levels and signaling [31, 32], makes it an attractive contender mediating the antitumor effects of CR. The gene discussed is IGF1; the disease is cancer.